Abstract
While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 113-119 |
| Number of pages | 7 |
| Journal | Emergency Medicine |
| Volume | 46 |
| Issue number | 2 |
| State | Published - Feb 2001 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Emergency Medicine
- Emergency Medical Services
Cite this
Offering mifepristone as an abortion option. / Pymar, Helen C.; Creinin, Mitchell D.
In: Emergency Medicine, Vol. 46, No. 2, 02.2001, p. 113-119.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Offering mifepristone as an abortion option
AU - Pymar, Helen C.
AU - Creinin, Mitchell D
PY - 2001/2
Y1 - 2001/2
N2 - While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.
AB - While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.
UR - http://www.scopus.com/inward/record.url?scp=0004718253&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0004718253&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0004718253
VL - 46
SP - 113
EP - 119
JO - Emergency Medicine
JF - Emergency Medicine
SN - 0013-6654
IS - 2
ER -